SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil

Bibliographic Details
Main Author: Gorayeb-Polacchini,Fernanda Salomão
Publication Date: 2021
Other Authors: Caldas,Heloisa Cristina, Bottazzo,Angelica Canovas, Abbud-Filho,Mario
Format: Article
Language: eng
Source: Brazilian Journal of Infectious Diseases
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000300203
Summary: ABSTRACT Background: The reported incidence and fatality rates of SARS-CoV-2 infection in patients receiving maintenance dialysis are higher than those of the general population. Objective: This study sought to characterize the clinical characteristics and outcomes following COVID-19 infection in this population in a single center in Brazil. Methods: Out of 497 dialysis patients evaluated between March 1st, 2020 and February 1st, 2021, those presenting symptoms or history of close contact with COVID-19 patients were tested. Disease severity was categorized as mild, moderate, or severe. Results: Out of the 497 patients, 8.8% tested positive for COVID-19. These patients were predominantly male (59%), mean age 57.5 ± 17. Hospitalization was required for 45.4% of patients and 15.9% received mechanical ventilation. Symptoms such as fever, cough, dyspnea and asthenia were more frequent in the severe group. Neutrophil to lymphocyte ratio, C- reactive protein, glutamic oxalacetic transaminase and lactic dehydrogenase were significantly higher in the severe group, while hemoglobin and lymphocyte counts were significantly lower. Chest CT >50% of ground glass lesions was the risk factor associated with severe disease and need for hospitalization. The incidence of a thromboembolic event was of 22.7% in this population. The incidence, mortality, and case fatality rates were 954.4/10,000 patients, 151.8/10,000 patients, and 15.9%, respectively. Conclusions: The incidence, mortality and case fatality rates in our cohort were significantly higher than those reported for the general population. To institute appropriate control measures and early vaccination in dialysis facilities is imperative to prevent the spread of COVID-19 infection.
id BSID-1_ff6f9073a4fe0d368ab71f7a3b1308cb
oai_identifier_str oai:scielo:S1413-86702021000300203
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in BrazilSARS-COV-2/COVID-19DialysisESRD/ESKDABSTRACT Background: The reported incidence and fatality rates of SARS-CoV-2 infection in patients receiving maintenance dialysis are higher than those of the general population. Objective: This study sought to characterize the clinical characteristics and outcomes following COVID-19 infection in this population in a single center in Brazil. Methods: Out of 497 dialysis patients evaluated between March 1st, 2020 and February 1st, 2021, those presenting symptoms or history of close contact with COVID-19 patients were tested. Disease severity was categorized as mild, moderate, or severe. Results: Out of the 497 patients, 8.8% tested positive for COVID-19. These patients were predominantly male (59%), mean age 57.5 ± 17. Hospitalization was required for 45.4% of patients and 15.9% received mechanical ventilation. Symptoms such as fever, cough, dyspnea and asthenia were more frequent in the severe group. Neutrophil to lymphocyte ratio, C- reactive protein, glutamic oxalacetic transaminase and lactic dehydrogenase were significantly higher in the severe group, while hemoglobin and lymphocyte counts were significantly lower. Chest CT >50% of ground glass lesions was the risk factor associated with severe disease and need for hospitalization. The incidence of a thromboembolic event was of 22.7% in this population. The incidence, mortality, and case fatality rates were 954.4/10,000 patients, 151.8/10,000 patients, and 15.9%, respectively. Conclusions: The incidence, mortality and case fatality rates in our cohort were significantly higher than those reported for the general population. To institute appropriate control measures and early vaccination in dialysis facilities is imperative to prevent the spread of COVID-19 infection.Brazilian Society of Infectious Diseases2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000300203Brazilian Journal of Infectious Diseases v.25 n.3 2021reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2021.101595info:eu-repo/semantics/openAccessGorayeb-Polacchini,Fernanda SalomãoCaldas,Heloisa CristinaBottazzo,Angelica CanovasAbbud-Filho,Marioeng2021-09-29T00:00:00Zoai:scielo:S1413-86702021000300203Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2021-09-29T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil
title SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil
spellingShingle SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil
Gorayeb-Polacchini,Fernanda Salomão
SARS-COV-2/COVID-19
Dialysis
ESRD/ESKD
title_short SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil
title_full SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil
title_fullStr SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil
title_full_unstemmed SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil
title_sort SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil
author Gorayeb-Polacchini,Fernanda Salomão
author_facet Gorayeb-Polacchini,Fernanda Salomão
Caldas,Heloisa Cristina
Bottazzo,Angelica Canovas
Abbud-Filho,Mario
author_role author
author2 Caldas,Heloisa Cristina
Bottazzo,Angelica Canovas
Abbud-Filho,Mario
author2_role author
author
author
dc.contributor.author.fl_str_mv Gorayeb-Polacchini,Fernanda Salomão
Caldas,Heloisa Cristina
Bottazzo,Angelica Canovas
Abbud-Filho,Mario
dc.subject.por.fl_str_mv SARS-COV-2/COVID-19
Dialysis
ESRD/ESKD
topic SARS-COV-2/COVID-19
Dialysis
ESRD/ESKD
description ABSTRACT Background: The reported incidence and fatality rates of SARS-CoV-2 infection in patients receiving maintenance dialysis are higher than those of the general population. Objective: This study sought to characterize the clinical characteristics and outcomes following COVID-19 infection in this population in a single center in Brazil. Methods: Out of 497 dialysis patients evaluated between March 1st, 2020 and February 1st, 2021, those presenting symptoms or history of close contact with COVID-19 patients were tested. Disease severity was categorized as mild, moderate, or severe. Results: Out of the 497 patients, 8.8% tested positive for COVID-19. These patients were predominantly male (59%), mean age 57.5 ± 17. Hospitalization was required for 45.4% of patients and 15.9% received mechanical ventilation. Symptoms such as fever, cough, dyspnea and asthenia were more frequent in the severe group. Neutrophil to lymphocyte ratio, C- reactive protein, glutamic oxalacetic transaminase and lactic dehydrogenase were significantly higher in the severe group, while hemoglobin and lymphocyte counts were significantly lower. Chest CT >50% of ground glass lesions was the risk factor associated with severe disease and need for hospitalization. The incidence of a thromboembolic event was of 22.7% in this population. The incidence, mortality, and case fatality rates were 954.4/10,000 patients, 151.8/10,000 patients, and 15.9%, respectively. Conclusions: The incidence, mortality and case fatality rates in our cohort were significantly higher than those reported for the general population. To institute appropriate control measures and early vaccination in dialysis facilities is imperative to prevent the spread of COVID-19 infection.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000300203
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000300203
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjid.2021.101595
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.25 n.3 2021
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209245195141120